Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Total Non-Current Liabilities (2023 - 2025)

Historic Total Non-Current Liabilities for Beta Bionics (BBNX) over the last 3 years, with Q3 2025 value amounting to $34.1 million.

  • Beta Bionics' Total Non-Current Liabilities changed N/A to $34.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.1 million, marking a year-over-year change of. This contributed to the annual value of $28.7 million for FY2024, which is 10733.1% up from last year.
  • Beta Bionics' Total Non-Current Liabilities amounted to $34.1 million in Q3 2025.
  • Over the past 5 years, Beta Bionics' Total Non-Current Liabilities peaked at $34.1 million during Q3 2025, and registered a low of $13.9 million during Q4 2023.
  • Moreover, its 3-year median value for Total Non-Current Liabilities was $27.3 million (2025), whereas its average is $25.6 million.
  • Data for Beta Bionics' Total Non-Current Liabilities shows a peak YoY increase of 10733.1% (in 2024) and a maximum YoY decrease of 10733.1% (in 2024) over the last 5 years.
  • Over the past 3 years, Beta Bionics' Total Non-Current Liabilities (Quarter) stood at $13.9 million in 2023, then skyrocketed by 107.33% to $28.7 million in 2024, then rose by 18.61% to $34.1 million in 2025.
  • Its Total Non-Current Liabilities stands at $34.1 million for Q3 2025, versus $27.3 million for Q2 2025 and $23.9 million for Q1 2025.